EUCTR2011-002821-24-IT进行中（未招募）不适用
Prospective pharmacodynamic study on patients with moderate, active Crohn’s disease treated with Rifaximin-EIR 400 mg tablets. - RETIC-PD/006/2011
ALFA WASSERMA0 个研究点开始时间: 2012年2月27日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •The study will include patients with active, moderate Crohn’s disease defined by a CDAI score of = 220 and = 400, localised in the ileocolon or colon (documented either radiologically or endoscopically at least 3 months before inclusion in the study).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 22
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 2
排除标准
- •Patients with symptoms attributed to Short Bowel Syndrome, patients potentially requiring immediate surgery for CD will be not included into the study.
研究者
相似试验
已完成
不适用
A study to evaluate the pharmacokinetic and pharmacodynamic equivalence of HSP-130 and United States-approved Neulasta (Registered Trademark) and European Union-approved Neulasta (Registered Trademark) administered as a single subcutaneous dose to healthy volunteers.The study will be conducted in healthy subjects. Neulasta is indicated for the treatment of cancer chemotherapy-induced neutropenia.Cancer - Any cancerACTRN12615001049561Hospira, Inc.150
尚未招募
Unknown
Study comparing anti-tuberculosis drug levels in saliva, plasma, and urine in patientsTuberculosisACTRN12623001088639Western Sydney Local Health District30
尚未招募
1 期
Effect of Jianpi Qushi Recipe on hyperuricemia patients and the serum levels of inflammatory cytokineshyperuricemia patientsITMCTR2200005783Department of Immunity,the Tianjin FirstHospital,Tianjin,
已完成
不适用
Study of two different formulations of finasteride in male volunteers with androgenetic alopeciaSkin and Connective Tissue DiseasesAndrogenic alopeciaAndrogenetic alopeciaISRCTN98903916Polichem S.A. (Switzerland)18
尚未招募
Unknown
Investigating the effect of imagery rescripting with and without medication on the symptoms of borderline personality disorderBorderline personality disorderIRCT20240610062067N1Zahedan University of Medical Sciences32